Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The ketogenic diet as a treatment paradigm for diverse neurological disorders.
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
The investigation of acute optic neuritis: a review and proposed protocol.
Multiple sclerosis and breast cancer.
Patients with migraine do not have MRI-visible cortical lesions.
Potassium-Retaining Diuretics: Amiloride
Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis.
Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis.
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients.
Managing fatigue in patients with multiple sclerosis.
The effects of massage therapy on multiple sclerosis patients' quality of life and leg function.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
Gilenya prescribing information
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
UVB light attenuates the systemic immune response in CNS autoimmunity.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta.
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1R ) and receptor-5 (S1P5R ) agonist with autoimmune disease-modifying activity.

Pages